Medicare evaluating coverage for $56,000 Alzheimer's drug

Medicare evaluating coverage for $56,000 Alzheimer's drug

Medicare is launching a formal process to decide whether to cover the new Alzheimer’s drug, Aduhelm, whose $56,000-a-year price tag and unproven benefits have prompted widespread criticism and a congressional investigation